Cargando…
The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer
BACKGROUND: Breast cancer is a common malignant disease, which may be caused by a number of genes deregulated by genomic or epigenomic events. Deregulated WNT/β-catenin signaling with accumulation of β-catenin is common in breast tumors, but mutations in WNT signaling pathway components have been ra...
Autores principales: | Björklund, Peyman, Svedlund, Jessica, Olsson, Anna-Karin, Åkerström, Göran, Westin, Gunnar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627768/ https://www.ncbi.nlm.nih.gov/pubmed/19158955 http://dx.doi.org/10.1371/journal.pone.0004243 |
Ejemplares similares
-
An LRP5 Receptor with Internal Deletion in Hyperparathyroid Tumors with Implications for Deregulated WNT/β-Catenin Signaling
por: Björklund, Peyman, et al.
Publicado: (2007) -
Aberrant WNT/β-catenin signaling in parathyroid carcinoma
por: Svedlund, Jessica, et al.
Publicado: (2010) -
Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients
por: Björklund, Peyman, et al.
Publicado: (2008) -
25-Hydroxyvitamin D(3 )1α-hydroxylase expression in breast cancer and use of non-1α-hydroxylated vitamin D analogue
por: Segersten, Ulrika, et al.
Publicado: (2005) -
In vitro stability of therapeutically relevant, internally truncated dystrophins
por: McCourt, Jackie L, et al.
Publicado: (2015)